Roche gets European approval for Tecentriq combo vs. lung cancer

Roche has received European Commission approval for its Tecentriq drug in combination with Avastin and chemotherapy as an initial treatment for people with a specific type of lung cancer, the Swiss pharma company said on Friday.

from Reuters: Health News https://ift.tt/2Hmqd9e